Christopher Del Prete

Non-Small Cell Lung Cancer in the Era of Personalized Medicine: Molecular Tests that Matter.

C. Azzoli, Christopher Del Prete, 2020, Rhode Island medical journal.

Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?—a narrative review

K. Almhanna, A. Muthiah, Christopher Del Prete, 2020, Annals of translational medicine.

The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient Sample

F. Lansigan, J. Shatzel, Christopher Del Prete, 2015, Clinical lymphoma, myeloma & leukemia.

Breast metastasis from colonic primary: a case report and review of the literature.

S. D. Del Prete, R. Babkowski, Christopher Del Prete, 2009, Connecticut medicine.

Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer

J. Farrell, K. Dragnev, G. Brooks, 2020, Heliyon.

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

R. Advani, Sonali M. Smith, J. Chavez, 2021, Blood.